Please login to the form below

Not currently logged in


This page shows the latest Elanco news and features for those working in and with pharma, biotech and healthcare.

GSK: we won’t be splitting up any time soon

The decision is in contrast to firms such as Novartis (selling its eyecare divison Alcon) and Lilly, which just announced the spin-off its animal health division Elanco.

Latest news

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2016 Deal Watch October 2016

    For Lilly this is a good deal as it acquired the Novartis Animal Health business for $4.5bn last year and Elanco, its animal health business, is now said to be

  • Pharma deals during April 2014 Pharma deals during April 2014

    Animal health:. The Novartis Animal Health franchise transaction is the 8th and largest acquisition for Elanco, Lilly's Animal Health arm, since 2007 and catapults it to the global number 2

  • Deal Watch table for April 2013 Deal Watch table for April 2013

    100. China Animal Health Care/ Elanco (Lilly). Part acquisition. Manufacturing, sale and distribution of animal drugs in China .

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...